Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04164082
Brief Title: Testing the Addition of an Anti-cancer Drug, Pembrolizumab, to the Usual Intravesical Chemotherapy Treatment (Gemcitabine) for the Treatment of BCG-Unresponsive Non-muscle Invasive Bladder Cancer

First Submitted : November 14, 2019
First Submitted that Met QC Criteria : November 14, 2019
First Posted : November 15, 2019

Last Update Submitted that Met QC Criteria : February 26, 2021
Last Update Posted : March 1, 2021